Holen Sie sich die Stockscreener-App
4.56
1.56%
0.07
Handel nachbörslich:
4.64
0.08
+1.75%
Schlusskurs vom Vortag:
$4.49
Offen:
$4.46
24-Stunden-Volumen:
304.28K
Relative Volume:
0.69
Marktkapitalisierung:
$80.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.54M
KGV:
-2.9419
EPS:
-1.55
Netto-Cashflow:
$-18.30M
1W Leistung:
-1.51%
1M Leistung:
+17.83%
6M Leistung:
+647.54%
1J Leistung:
+1,078%
1-Tages-Spanne:
$4.337
$4.74
1-Wochen-Bereich:
$4.325
$4.87
52-Wochen-Spanne:
$0.376
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
Firmenname
Unicycive Therapeutics Inc
Sektor
Branche
Telefon
650-384-0642
Adresse
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Vergleichen Sie UNCY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
4.56 | 79.30M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | Guggenheim | Buy |
| 2024-04-04 | Eingeleitet | Piper Sandler | Overweight |
Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten
UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
When Will Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Turn A Profit? - Yahoo Finance
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
The Gross Law Firm Reminds Unicycive Therapeutics, Inc. - GlobeNewswire
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
Unicycive Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsUNCY - MarketScreener
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
The Gross Law Firm Reminds Unicycive Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 – UNCY - GlobeNewswire Inc.
Portnoy Law Firm Announces Class Action on Behalf of Unicycive Therapeutics, Inc. Investors - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain OfficersUNCY - PR Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - The AI Journal
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
UNICYCIVE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Unicycive Therapeutics, Inc.(UNCY) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Class Action Alert: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of October 14, 2025 Deadline - ACCESS Newswire
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to ... - Caledonian Record
Join Class Action to Recover Losses from Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
Recover Investment Losses: Class Action Initiated Against Unicycive Therapeutics, Inc. (UNCY) - ACCESS Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
UNICYCIVE REMINDER: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
UNCY Stockholders Have Opportunity to Lead Unicycive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
Unicycive Therapeutics' (UNCY) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Investors in Unicycive Therapeutics, Inc. Should Contact - GlobeNewswire
Shareholders SueWallSt in New Class Action Against Unicycive Therapeutics, Inc.Act Now - Nasdaq
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for InvestorsContact The Gross Law Firm - Barchart.com
UNCY Investors have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
Investors in Unicycive Therapeutics, Inc. (UNCY): Protect Your RightsContact Levi & Korsinsky Before October 14, 2025 - Newsfile
UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
Holzer & Holzer, LLC Reminds Investors of Upcoming October - GlobeNewswire
Investor Alert: Deadline Approaching to Join Unicycive Therapeutics, Inc. (UNCY) Class ActionContact Levi & Korsinsky - Newsfile
Important Notice to Long-Term Shareholders of Humana Inc. - GlobeNewswire
Shareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Sahm
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky Before October 14, 2025 to Join Class Action - ACCESS Newswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
What machine learning models say about Unicycive Therapeutics Inc.July 2025 Market Mood & Precise Buy Zone Tips - newser.com
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive - The National Law Review
Securities Fraud Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY)Levi & Korsinsky Reminds Investors of October 14, 2025 - ACCESS Newswire
Did You Lose Money on Unicycive Therapeutics, Inc. (UNCY)? Levi & Korsinsky Urges Investors to Act Before October 14, 2025 - ACCESS Newswire
What analysts say about Unicycive Therapeutics Inc stockFundamental Stock Analysis & Small Investment Capital Tips - earlytimes.in
Unicycive Therapeutics: Interview With Founder & CEO Dr. Shalabh Gupta About The Kidney Therapy Company - Pulse 2.0
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
UNICYCIVE LAWSUIT ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive - MarketScreener
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):